Sign in to view content

Wet AMD 4 Symposium

Video
Published 2020

Related

A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
Treatment course and outcomes of neovascular age-related macular degeneration in patients receiving intraocular pressure-lowering drops
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2019
Deferred Compensation? Tax Cuts and the Jobs Act What You Need to Know
Robert C. Wang, MD, FASRS
Updates from the Field
2018

Category: AMD-Neovascular

See more

Annual Meeting Talks